Admission to Specialist Fund Market

RNS Number : 6510E
Axiom European Financial Debt Fd Ld
05 November 2015
 



NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

5 November 2015

 

Axiom European Financial Debt Fund Limited

Admission to Specialist Fund Market

Axiom European Financial Debt Fund Limited (the "Company") is pleased to announce the successful completion of its IPO, following the Placing of ordinary shares to raise gross proceeds of £50,737,667 at an Issue Price of 100 pence per Share. Admission of the Shares to trading on the Specialist Fund Market of the London Stock Exchange is expected to commence at 8.00 a.m. today.

Liberum Capital Limited acted as Sole Financial Adviser and Bookrunner to the Company.

The ISIN for the shares is GG00BTC2K735 and the SEDOL is BTC2K73.

The Shares will be traded under the code "AXI" from Admission.

Axiom Alternative Investments SARL

David Benamou, Managing Partner

Jerome Legras, Managing Partner

Tel: + 44 (0)20 3807 0670


Liberum Capital (Sole Financial Adviser and Bookrunner)

Shane Le Prevost / Richard Crawley / Richard Bootle / Robert Johnson

Tel:  +44 (0)20 3100 2222

MHP Communications (Financial PR Adviser)

Reg Hoare / Giles Robinson / Ollie Hoare / Iva Kodjabacheva

Tel:  +44 (0)20 3128 8100

 

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons distributing this announcement must satisfy themselves that it is lawful to do so. The Company assumes no responsibility in the event there is a violation by any person of such restrictions.

Liberum Capital Limited ("Liberum"), which is authorised and regulated by the Financial Conduct Authority, is acting only for the Company in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Liberum or advice to any other person in relation to the matters contained herein.

This announcement may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States.  This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States.  Securities may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The securities mentioned herein have not been, and will not be, registered under the Securities Act and will not be offered to the public in the United States.  The Company has not been, and will not be, registered under the US Investment Company Act of 1940, as amended.

Neither this announcement nor any copy of it may be taken or transmitted into or distributed in any member state of the European Economic Area (other than the United Kingdom), Canada, Australia, the Republic of South Africa or Japan or to any resident thereof.  Any failure to comply with these restrictions may constitute a violation of the securities laws or the laws of any such jurisdiction.  The distribution of this announcement in other jurisdictions may be restricted by law and the persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSRLDLEIIE
UK 100